Edwards Lifesciences (EW) Gains from Investment Securities (2016 - 2025)
Edwards Lifesciences (EW) posted Gains from Investment Securities of -$12.5 million for Q3 2025, up 53.53% on a QoQ basis from -$26.9 million in Q2 2023.
Powered by 
Analysis
Edwards Lifesciences (EW) Gains from Investment Securities (2016 - 2025) Analysis & Trends
Edwards Lifesciences has reported Gains from Investment Securities for 9 years, with the latest figure at -$12.5 million in Q3 2025.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$12.5 million in Q3 2025; TTM through Dec 2025 was -$12.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$12.5 million, changed N/A from the prior year.
- Gains from Investment Securities was -$12.5 million for Q3 2025 at Edwards Lifesciences, up from -$26.9 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $1.1 million in Q3 2021, with the low at -$102.6 million in Q2 2021.
- Average Gains from Investment Securities over 4 years is -$18.1 million, with a median of -$12.5 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities slumped 1236.36% in 2022, then surged 124.14% in 2023.
- Over 4 years, Gains from Investment Securities stood at -$18.1 million in 2021, then jumped by 102.76% to $500000.0 in 2022, then sank by 5480.0% to -$26.9 million in 2023, then surged by 53.53% to -$12.5 million in 2025.
- The last three Gains from Investment Securities figures came in at -$12.5 million (Q3 2025), -$26.9 million (Q2 2023), and $700000.0 (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.63 Bn | 178.03 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn |
| 3 | Medtronic | 118.51 Bn | 109.69 Bn | 6.34 Bn |
| 4 | Stryker | 106.53 Bn | 103.06 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.52 Bn | 65.98 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.57 Bn | 45.32 Bn | 1.35 Bn |
| 7 | Alcon | 34.00 Bn | 32.55 Bn | 1.68 Bn |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -12.50 Mn |
| Jun 30, 2023 | -26.90 Mn |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Sep 30, 2022 | -12.50 Mn |
| Jun 30, 2022 | -20.90 Mn |
| Mar 31, 2022 | -2.90 Mn |
| Dec 31, 2021 | -18.10 Mn |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | -102.60 Mn |
| Mar 31, 2021 | -4.50 Mn |
| Dec 31, 2020 | 5.20 Mn |
| Sep 30, 2020 | -9.00 Mn |
| Jun 30, 2020 | 19.60 Mn |
| Mar 31, 2020 | -2.20 Mn |
| Dec 31, 2019 | -18.50 Mn |
| Sep 30, 2019 | -2.30 Mn |
| Jun 30, 2019 | 8.00 Mn |
| Mar 31, 2019 | 6.70 Mn |
| Dec 31, 2018 | -14.00 Mn |